| 1 |
De Pauw B,Walsh TJ,Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group[J]. Clin Infect Dis, 2008, 46(12): 1813-1821.
|
| 2 |
Vandewoude KH,Blot SI,Benoit D, et al. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence[J]. J Hosp Infect, 2004, 56(4): 269-276.
|
| 3 |
He H,Jiang S,Zhang L, et al. Aspergillus tracheobro-nchitis in critically ill patients with chronic obstructive pulmonary diseases[J]. Mycoses, 2014, 57(8): 473-482.
|
| 4 |
Trof RJ,Beishuizen A,Debets-Ossenkopp YJ, et al. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients[J]. Intensive Care Med, 2007, 33(10): 1694-1703.
|
| 5 |
Garnacho-Montero J,Amaya-Villar R,Ortiz-Leyba C, et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome[J]. Crit Care, 2005, 9(3): R191-R199.
|
| 6 |
Park SJ,Mehrad B. Innate immunity to Aspergillus sp- ecies[J]. Clin Microbiol Rev, 2009, 22(4): 535-551.
|
| 7 |
Cui N,Wang H,Long Y, et al. CD8+ Tcell counts: an early predictor of risk and mortality in critically ill immunocompromised patients with invasive pulmonary aspergillosis[J]. Crit Care, 2013, 17(4): R157.
|
| 8 |
Paholcsek M,Fidler G,Konya J, et al. Combining stan-dard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropenia[J]. BMC Infect Dis, 2015(15): 251.
|
| 9 |
Kontoyiannis DP,Marr KA,Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database[J]. Clin Infect Dis, 2010, 50(8): 1091-1100.
|
| 10 |
Fortun J,Meije Y,Fresco G, et al. Aspergillosis. Clinical forms and treatment[J]. Enferm Infecc Microbiol Clin, 2012, 30(4): 201-208.
|
| 11 |
Garnacho-Montero J,Olaechea P,Alvarez-Lerma F, et al. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient[J]. Rev Esp Quimioter, 2013, 26(2): 173-188.
|
| 12 |
He H,Ding L,Li F, et al. Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study[J]. Crit Care, 2011, 15(1): R5.
|
| 13 |
Laurendi G,Mele S,Centanni S, et al. Global alliance against chronic respiratory diseases in Italy (GARD-Italy): strategy and activities[J]. Respir Med, 2012, 106(1): 1-8.
|
| 14 |
Guinea J,Torres-Narbona M,Gijón P, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome[J]. Clin Microbiol Infect, 2010, 16(7): 870-877.
|
| 15 |
Bulpa P,Dive A,Sibille Y. Invasive pulmonary asper-gillosis in patients with chronic obstructive pulmonary disease[J]. Eur Respir J, 2007, 30(4): 782-800.
|
| 16 |
Tutar N,Metan G,Koc AN, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease[J]. Multidiscip Respir Med, 2013, 8(1): 59.
|
| 17 |
沈毅弘,周华. 重视慢性阻塞性肺疾病重症患者继发侵袭性肺曲霉菌病的诊治[J/CD]. 中华危重症医学杂志：电子版, 2011, 4(2)：71-74.
|
| 18 |
Wu Z,Ling Z,Shao F, et al. Invasive pulmonary asper-gillosis in patients with acute-on-chronic liver failure[J]. J Int Med Res, 2012, 40(5): 1958-1965.
|
| 19 |
陶然,丁贤,陈勃江. 肝衰竭合并侵袭性肺曲霉病9例[J]. 西部医学, 2009, 21(9)：1636-1637.
|
| 20 |
方央. 乙肝性肝硬化合并院内真菌感染51例回顾分析[J/CD]. 中华危重症医学杂志：电子版, 2011, 4(5)：322-324.
|
| 21 |
Peghin M,Ruiz-Camps I,Garcia-Vidal C, et al. Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors[J]. J Infect, 2014, 69(4): 387-395.
|
| 22 |
Wauters J,Baar I,Meersseman P, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study[J]. Intensive Care Med, 2012, 38(11): 1761-1768.
|
| 23 |
Sedger LM,Hou S,Osvath SR, et al. Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha[J]. J Immunol, 2002, 169(11): 6193-6201.
|
| 24 |
Lionakis MS,Kontoyiannis DP. Glucocorticoids and invasive fungal infections[J]. Lancet, 2003, 362(9398): 1828-1838.
|
| 25 |
Blot SI,Taccone FS,Van den Abeele AM, et al. A clnical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients[J]. Am J Respir Crit Care Med, 2012, 186(1): 56-64.
|
| 26 |
Agusti C,Ranó A,Filella X, et al. Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: etiology, prognostic factors, and associated inflammatory response[J]. Chest, 2003, 123(2): 488-498.
|
| 27 |
Lugosi M,Alberti C,Zahar JR, et al. Aspergillus in the lower respiratory tract of immunocompetent critically ill patients[J]. J Infect, 2014, 69(3): 284-292.
|
| 28 |
de Hemptinne Q,Remmelink M,Brimioulle S, et al. ARDS: a clinicopathological confrontation[J]. Chest, 2009, 135(4): 944-949.
|
| 29 |
Monneret G,Venet F,Pachot A, et al. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony[J]. Mol Med, 2008, 14(1-2): 64-78.
|
| 30 |
Landelle C,Lepape A,Voirin N, et al. Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock[J]. Intensive Care Med, 2010, 36(11): 1859-1866.
|
| 31 |
Hartemink KJ,Paul MA,Spijkstra JJ, et al. Immuno-paralysis as a cause for invasive aspergillosis?[J]. Intensive Care Med, 2003, 29(11): 2068-2071.
|